Aspira Women's Health Inc. Reports Board and Compensation Changes

Ticker: AWHL · Form: 8-K · Filed: Dec 16, 2024 · CIK: 926617

Aspira Women'S Health INC. 8-K Filing Summary
FieldDetail
CompanyAspira Women'S Health INC. (AWHL)
Form Type8-K
Filed DateDec 16, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.001, $375,000, $135,000
Sentimentneutral

Sentiment: neutral

Topics: board-changes, executive-compensation, governance

Related Tickers: AWHI

TL;DR

Aspira Women's Health Inc. (AWHI) filed an 8-K detailing board changes and executive comp updates as of Dec 16, 2024.

AI Summary

Aspira Women's Health Inc. announced on December 16, 2024, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain directors and the election of new ones, alongside updates to compensatory plans for key officers.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance, impacting investor confidence.

Risk Assessment

Risk Level: medium — Changes in board and executive compensation can indicate internal shifts that may affect future business operations and financial performance.

Key Players & Entities

FAQ

What specific items are covered in the Form 8-K filed by Aspira Women's Health Inc. on December 16, 2024?

The Form 8-K covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, as well as financial statements and exhibits.

Who is the filer of this Form 8-K?

The filer is Aspira Women's Health Inc.

On what date was this Form 8-K reported?

The earliest event reported was on December 16, 2024.

In which state was Aspira Women's Health Inc. incorporated?

Aspira Women's Health Inc. was incorporated in Delaware.

What is the SEC file number for Aspira Women's Health Inc.'s filing?

The SEC file number is 001-34810.

Filing Stats: 598 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-12-16 17:13:39

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aspira Women's Health Inc. Date: December 16, 2024 By: /s/ Sandra Milligan Sandra Milligan, Interim Chief Executive Officer -3-

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing